Minerva Neurosciences reported $6.97M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Adma Biologics ADMA:US $ 16.94M 33.64M
ALKERMES ALKS:US 310.68M 5.55M
AstraZeneca AZN:LN 10.23B 280M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Bristol Myers Squibb BMY:US $ 9.3B 202M
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Johnson & Johnson JNJ:US $ 18.18B 616M
Marinus Pharmaceuticals MRNS:US $ 38.56M 7.66M
Merk MRK:US $ 9666M 666M
Minerva Neurosciences NERV:US $ 6.97M 1.02M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Novavax NVAX:US $ 668.88M 174.21M
Pfizer PFE:US $ 15640M 148M
Takeda 4502:JP 821.95B 52.96B
Vanda Pharmaceuticals VNDA:US $ 60.93M 6.93M